H. Kurebe

发表

Successful continuous nivolumab therapy for metastatic non‐small cell lung cancer after local treatment of oligometastatic lesions

S. Tobita, S. Koyama, Yoshihiko Utsu, 2020, Thoracic cancer.

Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression.

M. Mori, Kohei Nishida, Y. Yano, 2018, Annals of translational medicine.

Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report

M. Mori, Kohei Nishida, Y. Yano, 2019, Thoracic cancer.

Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study

M. Mori, Kohei Nishida, Y. Yano, 2018, PloS one.

Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.

K. Masuda, K. Nishida, K. Rokutan, 2014, American journal of physiology. Cell physiology.

Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary disease

K. Tsujino, R. Maekura, S. Kitada, 2018, Journal of breath research.

Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan

J. Uchida, Hidekazu Suzuki, Y. Fukuda, 2019, PloS one.

Improvement of exertional dyspnea and breathing pattern of inspiration to expiration after bronchial thermoplasty

K. Tsujino, S. Kitada, M. Miki, 2018, Allergy, Asthma & Clinical Immunology.

Three Cases of Idiopathic Diffuse Pulmonary Ossification

M. Mori, K. Tsujino, S. Kitada, 2018, Internal medicine.